ArticleEpilepsia2026
Mortality in functional seizures: Evidence from a large electronic health records dataset.
Article in Epilepsia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Functional/dissociative seizures as a neuroenergetic deficit syndrome: a brain economy failure hypothesis.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSeveral studies have found that people with functional seizures (FS) have increased mortality, approaching that of epilepsy (epileptic seizures [ES]). The small numbers of deaths in these studies make it unclear whether they can be attributed to comorbidities. We used a very large electronic health database to compare mortality in FS and ES, controlling for comorbidity.
methodsWe searched the TriNetX database for people with FS and no ES, people with ES and no FS, and people with neither FS nor ES (NS). We compared mortality while controlling for demographics and comorbid conditions.
resultsWe identified 1 916 787 people with ES, 32 854 people with FS, and 21 053 667 healthy controls. FS had rates of mental and physical comorbidities that were higher than NS and, for most categories, higher than ES. The risk of death (hazard ratio [HR]) in ES compared to FS was 2.99 (95% confidence interval [CI] = 2.81-3.18), which was reduced to 2.07 (95% CI = 1.92-2.24) when matched for 31 demographic and health factors. The risk of death in NS compared to FS was .56 (95% CI = .53-.59); after matching for demographics and mood disorders, this was .48 (95% CI = .44-.53). Matched sensitivity analyses suggest this was particularly pronounced in the year following diagnosis (HR = .39, 95% CI = .33-.47) and in the 5th decade of life (HR = .38, 95% CI = .27-.52). SIGNIFICANCE: FS confers approximately doubled mortality over that conferred by its comorbidities, although still only half of that conferred by ES, most prominently after diagnosis and in early middle age.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.